GLP2 is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide has demonstrated significant potential in preclinical and clinical research focused on metabolic regulation, glucose homeostasis, and body composition studies. Supplied as a lyophilized powder in a sealed vial for reconstitution. For research use only — not for human consumption.
Sequence: Dual GIP/GLP-1 receptor agonist with C20 fatty diacid chain

